Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013008
Filing Date
2018-05-10
Accepted
2018-05-10 16:43:25
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20180331.htm 10-Q 1369641
2 EX-10.1 pbyi-ex101_258.htm EX-10.1 826413
3 EX-10.2 pbyi-ex102_259.htm EX-10.2 726011
4 EX-31.1 pbyi-ex311_154.htm EX-31.1 9305
5 EX-31.2 pbyi-ex312_153.htm EX-31.2 9320
6 EX-32.1 pbyi-ex321_152.htm EX-32.1 6266
7 EX-32.2 pbyi-ex322_151.htm EX-32.2 6282
8 GRAPHIC g201805102022569083588.jpg GRAPHIC 2527
  Complete submission text file 0001564590-18-013008.txt   7523200

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT pbyi-20180331.xml EX-101.INS 1404501
10 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20180331.xsd EX-101.SCH 44544
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20180331_cal.xml EX-101.CAL 41040
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20180331_def.xml EX-101.DEF 130314
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20180331_lab.xml EX-101.LAB 371951
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20180331_pre.xml EX-101.PRE 269153
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 18823254
SIC: 2834 Pharmaceutical Preparations